Piricopril acetate

醋酸吡可利布

Report date: 2022/09/13 15:31:57
NME

Base Information

Drug NamePiricopril acetate
Drug Alias NamePY-34-AC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 1 inhibitors
TargetsCheckpoint kinase 1
Therapy Area/IndicationsLeukemia, Biphenotypic, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesZhejiang UniversityBiopolar Hongye (Nantong) Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBiopolar Hongye (Nantong) Pharmaceutical Co LtdZhejiang UniversityShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsLeukemia, Biphenotypic, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A